Thermo Fisher (TMO) news
Recent news
Glenview boosts GPN, TMO, DHR, META, THC in 2Q: 13F
Glenview Capital Management, LLC, a New York-based investment firm, reported its holdings in the Q2 2026 13F filing, revealing changes in its portfolio. The firm increased its positions in several stocks, including Global Payments Inc. (GPN), Thermo Fisher Scientific Inc. (THC), and others. The…
AInvest Wire · Aug 14, 2026D1 Capital Partners adds SPCX, META, ISRG, COMP, LIN in 2Q: 13F
D1 Capital Partners, a hedge fund with $10.7 billion in assets under management (AUM), disclosed its latest portfolio changes in its 13F filing for the second quarter of 2026. The firm added several new positions, including SPCX, META, ISRG, COMP, and LIN, reflecting its strategic allocation shifts…
AInvest Wire · Aug 14, 2026Thermo Fisher Scientific completes sale of its microbiology business to Astorg
AInvest Wire · Aug 12, 2026Solventum Corporation: Wells Fargo raises target price to $89 from $70
Solventum Corporation (NYSE:SOLV) has seen an upward revision in its price target from Wells Fargo, which raised its target to $82 from $79, while maintaining an Equal Weight rating on the stock as of September 15. This adjustment follows the company’s recent $4 billion P&F sale to Thermo Fisher…
AInvest Wire · Aug 6, 2026Thermo Fisher Scientific Inc: Stifel raises target price to $650 from $600
AInvest Wire · Aug 5, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.